Recent Drug Development Research for March 2025
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Narcolepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Pain, Arthritis, Osteoporosis, Drug Discovery
| Binge Eating Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Obesity, Drug Discovery
| Acne Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Dermatology
| Rosacea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Dermatology
| Vitiligo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Dermatology
| Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Renal
| Overactive Bladder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Haemophilus Influenzae Type B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Influenza, Drug Discovery
| Neisseria Meningitidis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Japanese Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Yellow Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Melanocortin Receptor 4 (MC4R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Hepatitis, Drug Discovery
| Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Clinical Trial
| Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Parkinson's Disease, Research & Development, Drug Discovery
| Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Real-world Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User - Global Forecast to 2029
Topics: Drug Development, EMR (Electronic Medical Record), Manufacturing & Packaging, Regulation, Pharmacy & Distribution, Drug Discovery, CNS/Neurology, Oncology/Hematology
Regions: Global
| Antimicrobial Susceptibility Testing Market, by Product (Manual {Susceptibility Discs, Plates, MIC Strips}, Consumables, Automated), Method (Diffusion, Dilution), Application (Clinical Diagnostics), End User (Hospitals, Pharma, Institutes) - Forecast to 2
Topics: Drug Development, Hospitals & Clinics, General In Vitro Diagnostics, Lab Testing Services, Antibiotic
| Pharmaceutical Contract Development & Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Injectable, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing}, End User [Large Pharma, Generic] - Global Forecast to 2029
Topics: Drug Development, Biologics, Generics Drugs, Manufacturing, Packaging & Detailing, Drug Discovery, Biopharmaceuticals, Clinical Nutrition
Regions: Global
| U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
Topics: Drug Development, Clinical Trial, CNS/Neurology, Oncology/Hematology
Regions: United States, Global
| Post-Operative Pain (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Pain, Drug Discovery, CNS/Neurology
| Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology, Behavioral Health
| Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Alopecia (Dermatology) - Drugs in Development, 2021
Topics: Drug Development, Hair Care, Drug Discovery, Dermatology
| Hidradenitis Suppurativa (Dermatology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Dermatology
| Venous Leg Ulcers (Crural ulcer) (Dermatology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Dermatology
| Primary Sclerosing Cholangitis (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Diarrhea (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Functional (Non Ulcer) Dyspepsia (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Hepatic Encephalopathy (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Prader-Willi Syndrome (PWS) (Genetic Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Acute Renal Failure (ARF) (Acute Kidney Injury) (Genitourinary Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Renal
| Nocturia (Genitourinary Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Urology
| Urinary Incontinence (Genitourinary Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Urology
| Myasthenia Gravis (Immunology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Allergy/Immunology
| Birch Pollen Allergy (Immunology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Allergy/Immunology
|
Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
